調査レポート | • レポートコード：QYR2104Z2858 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、HIV診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、アッセイ、キット・試薬、その他の消耗品、機器、ソフトウェア・サービス）、用途別市場規模（抗体検査、ウイルス量検査、CD4検査、乳幼児早期診断検査、ウイルス同定検査）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・HIV診断の市場動向 ・企業の競争状況、市場シェア ・HIV診断の種類別市場規模（消耗品、アッセイ、キット・試薬、その他の消耗品、機器、ソフトウェア・サービス） ・HIV診断の用途別市場規模（抗体検査、ウイルス量検査、CD4検査、乳幼児早期診断検査、ウイルス同定検査） ・HIV診断の北米市場規模2016-2027（アメリカ、カナダ） ・HIV診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・HIV診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・HIV診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・HIV診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Abbott Healthcare、Abbvie Inc.、Brsitol-Myers Squibb、Janssen Therapeutics、Gilead Sciences、Merck & Co. Inc、VIIV Healthcare、BD Biosciences、Beckman Coulter、Partec、Sysmex、Apogee Flow Systems、PointCare Technologies Inc.、Zyomyx Inc.、Mylan inc.、Roche Diagnostics、Siemens Healthcare、Qiagen、BioMerieux） ・結論 |
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.
Market Analysis and Insights: Global HIV Diagnostics Market
The global HIV Diagnostics market size is projected to reach US$ 4697.7 million by 2026, from US$ 2636.2 million in 2019, at a CAGR of 8.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HIV Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HIV Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HIV Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HIV Diagnostics market.
Global HIV Diagnostics Scope and Market Size
HIV Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HIV Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Segment by Application
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Brsitol-Myers Squibb
Janssen Therapeutics
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Consumables
1.2.3 Assay, Kits and Reagents
1.2.4 Other Consumables
1.2.5 Instruments
1.2.6 Software and Services
1.3 Market by Application
1.3.1 Global HIV Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Antibody Tests
1.3.3 Viral Load Tests
1.3.4 CD4 Tests
1.3.5 Tests for Early Infant Diagnosis
1.3.6 Tests for Viral Identification
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HIV Diagnostics Market Perspective (2016-2027)
2.2 HIV Diagnostics Growth Trends by Regions
2.2.1 HIV Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HIV Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 HIV Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 HIV Diagnostics Industry Dynamic
2.3.1 HIV Diagnostics Market Trends
2.3.2 HIV Diagnostics Market Drivers
2.3.3 HIV Diagnostics Market Challenges
2.3.4 HIV Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Diagnostics Players by Revenue
3.1.1 Global Top HIV Diagnostics Players by Revenue (2016-2021)
3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HIV Diagnostics Revenue
3.4 Global HIV Diagnostics Market Concentration Ratio
3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2020
3.5 HIV Diagnostics Key Players Head office and Area Served
3.6 Key Players HIV Diagnostics Product Solution and Service
3.7 Date of Enter into HIV Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Diagnostics Breakdown Data by Type
4.1 Global HIV Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global HIV Diagnostics Forecasted Market Size by Type (2022-2027)
5 HIV Diagnostics Breakdown Data by Application
5.1 Global HIV Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global HIV Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America HIV Diagnostics Market Size (2016-2027)
6.2 North America HIV Diagnostics Market Size by Type
6.2.1 North America HIV Diagnostics Market Size by Type (2016-2021)
6.2.2 North America HIV Diagnostics Market Size by Type (2022-2027)
6.2.3 North America HIV Diagnostics Market Size by Type (2016-2027)
6.3 North America HIV Diagnostics Market Size by Application
6.3.1 North America HIV Diagnostics Market Size by Application (2016-2021)
6.3.2 North America HIV Diagnostics Market Size by Application (2022-2027)
6.3.3 North America HIV Diagnostics Market Size by Application (2016-2027)
6.4 North America HIV Diagnostics Market Size by Country
6.4.1 North America HIV Diagnostics Market Size by Country (2016-2021)
6.4.2 North America HIV Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe HIV Diagnostics Market Size (2016-2027)
7.2 Europe HIV Diagnostics Market Size by Type
7.2.1 Europe HIV Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe HIV Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe HIV Diagnostics Market Size by Type (2016-2027)
7.3 Europe HIV Diagnostics Market Size by Application
7.3.1 Europe HIV Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe HIV Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe HIV Diagnostics Market Size by Application (2016-2027)
7.4 Europe HIV Diagnostics Market Size by Country
7.4.1 Europe HIV Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe HIV Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific HIV Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific HIV Diagnostics Market Size by Type
8.2.1 Asia-Pacific HIV Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HIV Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HIV Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific HIV Diagnostics Market Size by Application
8.3.1 Asia-Pacific HIV Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HIV Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HIV Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific HIV Diagnostics Market Size by Region
8.4.1 Asia-Pacific HIV Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HIV Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America HIV Diagnostics Market Size (2016-2027)
9.2 Latin America HIV Diagnostics Market Size by Type
9.2.1 Latin America HIV Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America HIV Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America HIV Diagnostics Market Size by Type (2016-2027)
9.3 Latin America HIV Diagnostics Market Size by Application
9.3.1 Latin America HIV Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America HIV Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America HIV Diagnostics Market Size by Application (2016-2027)
9.4 Latin America HIV Diagnostics Market Size by Country
9.4.1 Latin America HIV Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America HIV Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa HIV Diagnostics Market Size by Type
10.2.1 Middle East & Africa HIV Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HIV Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HIV Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa HIV Diagnostics Market Size by Application
10.3.1 Middle East & Africa HIV Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HIV Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HIV Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa HIV Diagnostics Market Size by Country
10.4.1 Middle East & Africa HIV Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HIV Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott HIV Diagnostics Introduction
11.1.4 Abbott Revenue in HIV Diagnostics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Details
11.2.2 Abbott Healthcare Business Overview
11.2.3 Abbott Healthcare HIV Diagnostics Introduction
11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2016-2021)
11.2.5 Abbott Healthcare Recent Development
11.3 Abbvie Inc.
11.3.1 Abbvie Inc. Company Details
11.3.2 Abbvie Inc. Business Overview
11.3.3 Abbvie Inc. HIV Diagnostics Introduction
11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2016-2021)
11.3.5 Abbvie Inc. Recent Development
11.4 Brsitol-Myers Squibb
11.4.1 Brsitol-Myers Squibb Company Details
11.4.2 Brsitol-Myers Squibb Business Overview
11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction
11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2016-2021)
11.4.5 Brsitol-Myers Squibb Recent Development
11.5 Janssen Therapeutics
11.5.1 Janssen Therapeutics Company Details
11.5.2 Janssen Therapeutics Business Overview
11.5.3 Janssen Therapeutics HIV Diagnostics Introduction
11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2016-2021)
11.5.5 Janssen Therapeutics Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences HIV Diagnostics Introduction
11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2016-2021)
11.6.5 Gilead Sciences Recent Development
11.7 Merck & Co. Inc
11.7.1 Merck & Co. Inc Company Details
11.7.2 Merck & Co. Inc Business Overview
11.7.3 Merck & Co. Inc HIV Diagnostics Introduction
11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2016-2021)
11.7.5 Merck & Co. Inc Recent Development
11.8 VIIV Healthcare
11.8.1 VIIV Healthcare Company Details
11.8.2 VIIV Healthcare Business Overview
11.8.3 VIIV Healthcare HIV Diagnostics Introduction
11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2016-2021)
11.8.5 VIIV Healthcare Recent Development
11.9 BD Biosciences
11.9.1 BD Biosciences Company Details
11.9.2 BD Biosciences Business Overview
11.9.3 BD Biosciences HIV Diagnostics Introduction
11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2016-2021)
11.9.5 BD Biosciences Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Details
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter HIV Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2016-2021)
11.10.5 Beckman Coulter Recent Development
11.11 Partec
11.11.1 Partec Company Details
11.11.2 Partec Business Overview
11.11.3 Partec HIV Diagnostics Introduction
11.11.4 Partec Revenue in HIV Diagnostics Business (2016-2021)
11.11.5 Partec Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Details
11.12.2 Sysmex Business Overview
11.12.3 Sysmex HIV Diagnostics Introduction
11.12.4 Sysmex Revenue in HIV Diagnostics Business (2016-2021)
11.12.5 Sysmex Recent Development
11.13 Apogee Flow Systems
11.13.1 Apogee Flow Systems Company Details
11.13.2 Apogee Flow Systems Business Overview
11.13.3 Apogee Flow Systems HIV Diagnostics Introduction
11.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2016-2021)
11.13.5 Apogee Flow Systems Recent Development
11.14 PointCare Technologies Inc.
11.14.1 PointCare Technologies Inc. Company Details
11.14.2 PointCare Technologies Inc. Business Overview
11.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction
11.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2016-2021)
11.14.5 PointCare Technologies Inc. Recent Development
11.15 Zyomyx Inc.
11.15.1 Zyomyx Inc. Company Details
11.15.2 Zyomyx Inc. Business Overview
11.15.3 Zyomyx Inc. HIV Diagnostics Introduction
11.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2016-2021)
11.15.5 Zyomyx Inc. Recent Development
11.16 Mylan inc.
11.16.1 Mylan inc. Company Details
11.16.2 Mylan inc. Business Overview
11.16.3 Mylan inc. HIV Diagnostics Introduction
11.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2016-2021)
11.16.5 Mylan inc. Recent Development
11.17 Roche Diagnostics
11.17.1 Roche Diagnostics Company Details
11.17.2 Roche Diagnostics Business Overview
11.17.3 Roche Diagnostics HIV Diagnostics Introduction
11.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2016-2021)
11.17.5 Roche Diagnostics Recent Development
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Details
11.18.2 Siemens Healthcare Business Overview
11.18.3 Siemens Healthcare HIV Diagnostics Introduction
11.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2016-2021)
11.18.5 Siemens Healthcare Recent Development
11.18 Qiagen
.1 Qiagen Company Details
.2 Qiagen Business Overview
.3 Qiagen HIV Diagnostics Introduction
.4 Qiagen Revenue in HIV Diagnostics Business (2016-2021)
.5 Qiagen Recent Development
11.20 BioMerieux
11.20.1 BioMerieux Company Details
11.20.2 BioMerieux Business Overview
11.20.3 BioMerieux HIV Diagnostics Introduction
11.20.4 BioMerieux Revenue in HIV Diagnostics Business (2016-2021)
11.20.5 BioMerieux Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global HIV Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Consumables
Table 3. Key Players of Assay, Kits and Reagents
Table 4. Key Players of Other Consumables
Table 5. Key Players of Instruments
Table 6. Key Players of Software and Services
Table 7. Global HIV Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global HIV Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global HIV Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global HIV Diagnostics Market Share by Regions (2016-2021)
Table 11. Global HIV Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global HIV Diagnostics Market Share by Regions (2022-2027)
Table 13. HIV Diagnostics Market Trends
Table 14. HIV Diagnostics Market Drivers
Table 15. HIV Diagnostics Market Challenges
Table 16. HIV Diagnostics Market Restraints
Table 17. Global HIV Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global HIV Diagnostics Market Share by Players (2016-2021)
Table 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnostics as of 2020)
Table 20. Ranking of Global Top HIV Diagnostics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by HIV Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players HIV Diagnostics Product Solution and Service
Table 24. Date of Enter into HIV Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global HIV Diagnostics Revenue Market Share by Type (2016-2021)
Table 28. Global HIV Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global HIV Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global HIV Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global HIV Diagnostics Revenue Market Share by Application (2016-2021)
Table 32. Global HIV Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global HIV Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific HIV Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific HIV Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa HIV Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa HIV Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa HIV Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa HIV Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa HIV Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa HIV Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott HIV Diagnostics Product
Table 67. Abbott Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. Abbott Healthcare Company Details
Table 70. Abbott Healthcare Business Overview
Table 71. Abbott Healthcare HIV Diagnostics Product
Table 72. Abbott Healthcare Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 73. Abbott Healthcare Recent Development
Table 74. Abbvie Inc. Company Details
Table 75. Abbvie Inc. Business Overview
Table 76. Abbvie Inc. HIV Diagnostics Product
Table 77. Abbvie Inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 78. Abbvie Inc. Recent Development
Table 79. Brsitol-Myers Squibb Company Details
Table 80. Brsitol-Myers Squibb Business Overview
Table 81. Brsitol-Myers Squibb HIV Diagnostics Product
Table 82. Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 83. Brsitol-Myers Squibb Recent Development
Table 84. Janssen Therapeutics Company Details
Table 85. Janssen Therapeutics Business Overview
Table 86. Janssen Therapeutics HIV Diagnostics Product
Table 87. Janssen Therapeutics Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 88. Janssen Therapeutics Recent Development
Table 89. Gilead Sciences Company Details
Table 90. Gilead Sciences Business Overview
Table 91. Gilead Sciences HIV Diagnostics Product
Table 92. Gilead Sciences Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 93. Gilead Sciences Recent Development
Table 94. Merck & Co. Inc Company Details
Table 95. Merck & Co. Inc Business Overview
Table 96. Merck & Co. Inc HIV Diagnostics Product
Table 97. Merck & Co. Inc Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 98. Merck & Co. Inc Recent Development
Table 99. VIIV Healthcare Company Details
Table 100. VIIV Healthcare Business Overview
Table 101. VIIV Healthcare Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 102. VIIV Healthcare Recent Development
Table 103. BD Biosciences Company Details
Table 104. BD Biosciences Business Overview
Table 105. BD Biosciences HIV Diagnostics Product
Table 106. BD Biosciences Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 107. BD Biosciences Recent Development
Table 108. Beckman Coulter Company Details
Table 109. Beckman Coulter Business Overview
Table 110. Beckman Coulter HIV Diagnostics Product
Table 111. Beckman Coulter Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 112. Beckman Coulter Recent Development
Table 113. Partec Company Details
Table 114. Partec Business Overview
Table 115. Partec HIV Diagnostics Product
Table 116. Partec Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 117. Partec Recent Development
Table 118. Sysmex Company Details
Table 119. Sysmex Business Overview
Table 120. Sysmex HIV Diagnostics Product
Table 121. Sysmex Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 122. Sysmex Recent Development
Table 123. Apogee Flow Systems Company Details
Table 124. Apogee Flow Systems Business Overview
Table 125. Apogee Flow Systems HIV Diagnostics Product
Table 126. Apogee Flow Systems Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 127. Apogee Flow Systems Recent Development
Table 128. PointCare Technologies Inc. Company Details
Table 129. PointCare Technologies Inc. Business Overview
Table 130. PointCare Technologies Inc. HIV Diagnostics Product
Table 131. PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 132. PointCare Technologies Inc. Recent Development
Table 133. Zyomyx Inc. Company Details
Table 134. Zyomyx Inc. Business Overview
Table 135. Zyomyx Inc. HIV Diagnostics Product
Table 136. Zyomyx Inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 137. Zyomyx Inc. Recent Development
Table 138. Mylan inc. Company Details
Table 139. Mylan inc. Business Overview
Table 140. Mylan inc. HIV Diagnostics Product
Table 141. Mylan inc. Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 142. Mylan inc. Recent Development
Table 143. Roche Diagnostics Company Details
Table 144. Roche Diagnostics Business Overview
Table 145. Roche Diagnostics HIV Diagnostics Product
Table 146. Roche Diagnostics Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 147. Roche Diagnostics Recent Development
Table 148. Siemens Healthcare Company Details
Table 149. Siemens Healthcare Business Overview
Table 150. Siemens Healthcare HIV Diagnostics Product
Table 151. Siemens Healthcare Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 152. Siemens Healthcare Recent Development
Table 153. Qiagen Company Details
Table 154. Qiagen Business Overview
Table 155. Qiagen HIV Diagnostics Product
Table 156. Qiagen Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 157. Qiagen Recent Development
Table 158. BioMerieux Company Details
Table 159. BioMerieux Business Overview
Table 160. BioMerieux HIV Diagnostics Product
Table 161. BioMerieux Revenue in HIV Diagnostics Business (2016-2021) & (US$ Million)
Table 162. BioMerieux Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Consumables Features
Figure 3. Assay, Kits and Reagents Features
Figure 4. Other Consumables Features
Figure 5. Instruments Features
Figure 6. Software and Services Features
Figure 7. Global HIV Diagnostics Market Share by Application: 2020 VS 2027
Figure 8. Antibody Tests Case Studies
Figure 9. Viral Load Tests Case Studies
Figure 10. CD4 Tests Case Studies
Figure 11. Tests for Early Infant Diagnosis Case Studies
Figure 12. Tests for Viral Identification Case Studies
Figure 13. HIV Diagnostics Report Years Considered
Figure 14. Global HIV Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global HIV Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global HIV Diagnostics Market Share by Regions: 2020 VS 2027
Figure 17. Global HIV Diagnostics Market Share by Regions (2022-2027)
Figure 18. Global HIV Diagnostics Market Share by Players in 2020
Figure 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnostics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by HIV Diagnostics Revenue in 2020
Figure 21. Global HIV Diagnostics Revenue Market Share by Type (2016-2021)
Figure 22. Global HIV Diagnostics Revenue Market Share by Type (2022-2027)
Figure 23. North America HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America HIV Diagnostics Market Share by Type (2016-2027)
Figure 25. North America HIV Diagnostics Market Share by Application (2016-2027)
Figure 26. North America HIV Diagnostics Market Share by Country (2016-2027)
Figure 27. United States HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe HIV Diagnostics Market Share by Type (2016-2027)
Figure 31. Europe HIV Diagnostics Market Share by Application (2016-2027)
Figure 32. Europe HIV Diagnostics Market Share by Country (2016-2027)
Figure 33. Germany HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific HIV Diagnostics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific HIV Diagnostics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific HIV Diagnostics Market Share by Region (2016-2027)
Figure 43. China HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America HIV Diagnostics Market Share by Type (2016-2027)
Figure 51. Latin America HIV Diagnostics Market Share by Application (2016-2027)
Figure 52. Latin America HIV Diagnostics Market Share by Country (2016-2027)
Figure 53. Mexico HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa HIV Diagnostics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa HIV Diagnostics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa HIV Diagnostics Market Share by Country (2016-2027)
Figure 59. Turkey HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE HIV Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbott Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 63. Abbott Healthcare Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 64. Abbvie Inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 65. Brsitol-Myers Squibb Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 66. Janssen Therapeutics Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 67. Gilead Sciences Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 68. Merck & Co. Inc Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 69. VIIV Healthcare Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 70. BD Biosciences Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 71. Beckman Coulter Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 72. Partec Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 73. Sysmex Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 74. Apogee Flow Systems Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 75. PointCare Technologies Inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 76. Zyomyx Inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 77. Mylan inc. Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 78. Roche Diagnostics Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 79. Siemens Healthcare Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 80. Qiagen Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 81. BioMerieux Revenue Growth Rate in HIV Diagnostics Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
世界のウイルス性肝炎＆レトロウイルス診断検査市場規模・現状・予測（2021年-2027年） Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patien…- 世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 世界のパパニコロウ検査＆HPV検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pap Tests and HPV Tests Market The global Pap Tests and HPV Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の分子診断検査・試薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Molecular Diagnostics Tests & Reagents Market The global Molecular Diagnostics Tests & Reagents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界のE型肝炎診断検査市場規模・現状・予測（2021年-2027年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 48 million by 2026, from US$ 42 million in 2019, at a CAGR of 2.2% during 2021-2026. With industry-st…